[go: up one dir, main page]

NO951281D0 - Fremgangsmåte for fremstilling av 10-desacetyl-baccatin-III - Google Patents

Fremgangsmåte for fremstilling av 10-desacetyl-baccatin-III

Info

Publication number
NO951281D0
NO951281D0 NO951281A NO951281A NO951281D0 NO 951281 D0 NO951281 D0 NO 951281D0 NO 951281 A NO951281 A NO 951281A NO 951281 A NO951281 A NO 951281A NO 951281 D0 NO951281 D0 NO 951281D0
Authority
NO
Norway
Prior art keywords
iii
desacetyl
baccatin
preparation
yew
Prior art date
Application number
NO951281A
Other languages
English (en)
Other versions
NO310414B1 (no
NO951281L (no
Inventor
Rodolphe Margraff
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO951281D0 publication Critical patent/NO951281D0/no
Publication of NO951281L publication Critical patent/NO951281L/no
Publication of NO310414B1 publication Critical patent/NO310414B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO19951281A 1992-10-05 1995-04-03 Fremgangsmåte for fremstilling av 10-desacetyl-baccatin-III NO310414B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9211745A FR2696462B1 (fr) 1992-10-05 1992-10-05 Procédé d'obtention de la désacétyl-10 baccatine III.
PCT/FR1993/000971 WO1994007881A1 (fr) 1992-10-05 1993-10-04 Procede d'obtention de la desacetyl-10 baccatine iii

Publications (3)

Publication Number Publication Date
NO951281D0 true NO951281D0 (no) 1995-04-03
NO951281L NO951281L (no) 1995-04-03
NO310414B1 NO310414B1 (no) 2001-07-02

Family

ID=9434123

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19951281A NO310414B1 (no) 1992-10-05 1995-04-03 Fremgangsmåte for fremstilling av 10-desacetyl-baccatin-III

Country Status (30)

Country Link
US (2) US5393896A (no)
EP (1) EP0663909B1 (no)
JP (1) JP3299753B2 (no)
KR (1) KR100301238B1 (no)
CN (1) CN1041310C (no)
AT (1) ATE147381T1 (no)
AU (1) AU680440B2 (no)
CA (2) CA2146248C (no)
CZ (2) CZ286452B6 (no)
DE (1) DE69307333T2 (no)
DK (1) DK0663909T3 (no)
EE (1) EE03124B1 (no)
ES (1) ES2095672T3 (no)
FI (1) FI109797B (no)
FR (1) FR2696462B1 (no)
GE (1) GEP19981433B (no)
GR (1) GR3022229T3 (no)
HU (1) HU225969B1 (no)
LT (1) LT3465B (no)
LV (1) LV10620B (no)
MX (1) MX9305770A (no)
NO (1) NO310414B1 (no)
NZ (1) NZ256449A (no)
PL (1) PL173993B1 (no)
RU (1) RU2108330C1 (no)
SK (1) SK280335B6 (no)
TW (1) TW404944B (no)
UA (1) UA40601C2 (no)
WO (1) WO1994007881A1 (no)
ZA (1) ZA937312B (no)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2290074T3 (es) 1993-07-19 2008-02-16 Angiotech Pharmaceuticals, Inc. Composiciones anti-angiogenicas que contienen taxol y un vehiculo no biodegradable y su uso.
FR2714053B1 (fr) * 1993-12-22 1996-03-08 Pf Medicament Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
CN1112433A (zh) * 1994-05-24 1995-11-29 郭明 红豆杉属植物提取物及其应用
CA2178541C (en) 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
FR2736355B1 (fr) * 1995-07-07 1997-11-07 Pf Medicament Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii
US5965752A (en) * 1996-08-23 1999-10-12 Institut National De La Recherche Scientifique Preparative scale isolation and purification of taxanes
ES2195378T3 (es) 1997-08-21 2003-12-01 Univ Florida State Procedimiento para la sintesis de taxanos.
US6066748A (en) * 1997-12-17 2000-05-23 Han; Man Woo Process of extracting TAXOL® from taxus cuspidata
PT1068192E (pt) * 1998-01-14 2002-11-29 Bristol Myers Squibb Co Novos complexos cristalinos de bacatina iii com imidazol 2-metilimidazol ou isopropanol
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) * 1999-01-07 1999-10-19 508037 (Nb) Inc. Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
US6495705B2 (en) 2000-03-16 2002-12-17 Napro Biotherapeutics, Inc. Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
US6281368B1 (en) 2000-03-16 2001-08-28 Napro Biotherapeutics, Inc. Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
CA2440935A1 (en) 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
EP1392254B1 (en) * 2001-04-20 2007-06-06 The University of British Columbia Micellar drug delivery systems for hydrophobic drugs
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
EP1594459B1 (en) 2002-12-30 2010-02-17 Angiotech International Ag Drug delivery from rapid gelling polymer composition
AU2003303565A1 (en) * 2002-12-31 2004-07-29 Natural Pharmaceuticals Inc. Pelletizing yew biomass for extraction of taxanes and other natural products
CA2525647A1 (en) 2003-05-16 2005-02-24 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
US8770459B2 (en) * 2003-10-17 2014-07-08 Covidien Lp Surgical stapling device with independent tip rotation
US7407973B2 (en) 2003-10-24 2008-08-05 Intermune, Inc. Use of pirfenidone in therapeutic regimens
US20060127510A1 (en) * 2003-12-30 2006-06-15 Natural Pharmaceuticals, Inc. Harvesting and pelletizing yew biomass for extraction of taxanes and other natural products
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US7846940B2 (en) 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US20050250954A1 (en) * 2004-05-04 2005-11-10 Phytogen Life Sciences Inc. Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
US20050240036A1 (en) * 2004-04-23 2005-10-27 Phytogen Life Sciences Inc. Semi-synthesis of taxane intermediates from a mixture of taxanes
US20050272807A1 (en) * 2004-06-04 2005-12-08 Phytogen Life Sciences Inc. Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
KR20070045219A (ko) * 2004-07-02 2007-05-02 아이박스 파마슈티컬스 에스.알.오. 파클리탁셀과 세팔로마닌의 분리 방법
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2006089218A2 (en) 2005-02-17 2006-08-24 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulating angiogenesis
WO2007045093A1 (en) * 2005-10-21 2007-04-26 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service Preparation of taxanes
WO2007107305A2 (en) 2006-03-22 2007-09-27 Medigene Ag Treatment of triple receptor negative breast cancer
WO2008005284A2 (en) 2006-06-30 2008-01-10 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
CN100404520C (zh) * 2006-08-15 2008-07-23 北京诺瑞医药技术有限公司 从欧洲红豆杉枝叶中提取分离10-去乙酰基巴卡汀ⅲ的方法
CN101230053B (zh) * 2007-12-04 2010-06-02 北京诺瑞医药技术有限公司 从红豆杉枝叶中超声提取分离10-去乙酰基巴卡汀ⅲ的方法
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
US8273404B2 (en) 2008-05-19 2012-09-25 Cordis Corporation Extraction of solvents from drug containing polymer reservoirs
EP2859916B1 (en) 2008-05-22 2017-11-29 Galera Labs, LLC Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy
WO2010005850A1 (en) 2008-07-08 2010-01-14 The J. David Gladstone Institutes Methods and compositions for modulating angiogenesis
US8642063B2 (en) 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20120302954A1 (en) 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
US20120303115A1 (en) 2011-05-25 2012-11-29 Dadino Ronald C Expandable devices coated with a rapamycin composition
EP2760848B1 (en) 2011-09-26 2018-11-28 Fresenius Kabi Oncology Limited Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
EP3539563A1 (en) 2012-07-19 2019-09-18 Redwood Bioscience, Inc. Antibody specific for cd22 and methods of use thereof
AU2013341711A1 (en) 2012-11-12 2015-05-21 Redwood Bioscience, Inc. Compounds and methods for producing a conjugate
LT2956175T (lt) 2013-02-15 2017-12-11 The Regents Of The University Of California Chimerinis antigeno receptorius ir jo panaudojimo būdai
CN105358531B (zh) 2013-03-14 2017-11-14 利兰-斯坦福大学初级学院的董事会 线粒体醛脱氢酶‑2调节剂和其使用方法
CN103508984B (zh) * 2013-10-22 2017-03-08 北京诺瑞医药技术有限公司 连续浸漉吸附富集法从红豆杉中提取10-dab的方法
JP6745218B2 (ja) 2013-11-27 2020-08-26 レッドウッド バイオサイエンス, インコーポレイテッド ヒドラジニル−ピロロ化合物及び複合体を生成するための方法
WO2015127137A1 (en) 2014-02-19 2015-08-27 Aldea Pharmaceuticals, Inc. Mitochondrial aldehyde dehydrogenase 2 (aldh2) binding polycyclic amides and their use for the treatment of cancer
US10517961B2 (en) 2015-09-25 2019-12-31 ZY Therapeutics, Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
US10654875B2 (en) 2015-11-12 2020-05-19 The Board Of Trustees Of The Leland Stanford Junior University Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
HUP1500603A2 (en) * 2015-12-11 2017-06-28 Rotachrom Tech Kft Process for the separation of 10-deacetyl baccatin iii
TWI760319B (zh) 2015-12-30 2022-04-11 杏國新藥股份有限公司 乳癌治療
JP2019515677A (ja) 2016-04-26 2019-06-13 アール.ピー.シェーラー テクノロジーズ エルエルシー 抗体複合体ならびにそれを作製および使用する方法
UA123020C2 (uk) 2016-06-01 2021-02-03 Сервьє Айпі Юкей Лімітед Склади поліалкіленоксид-аспарагінази та способи їхнього виготовлення й використання
CN106397371A (zh) * 2016-08-31 2017-02-15 重庆市碚圣医药科技股份有限公司 一种用曼地亚红豆杉高产10‑dabⅲ的方法
TWI852903B (zh) 2017-01-05 2024-08-21 杏國新藥股份有限公司 胰臟癌治療
SG11201906468TA (en) 2017-01-18 2019-08-27 F1 Oncology Inc Chimeric antigen receptors against axl or ror2 and methods of use thereof
EP3388082A1 (en) 2017-04-13 2018-10-17 Galera Labs, LLC Combination cancer immunotherapy with pentaaza macrocyclic ring complex
WO2018218004A1 (en) 2017-05-24 2018-11-29 The Board Of Regents Of The University Of Texas System Linkers for antibody drug conjugates
EA202091832A1 (ru) 2018-01-31 2021-01-11 ГАЛЕРА ЛЭБЗ, ЭлЭлСи Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины
BR112020020930A2 (pt) 2018-04-11 2021-03-02 Ohio State Innovation Foundation composição de liberação de fármaco, método para tratar um distúrbio oftalmológico e kit
US11897928B2 (en) 2018-07-18 2024-02-13 Manzanita Pharmaceuticals, Inc. Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
US11529402B2 (en) 2019-01-14 2022-12-20 Ignite Immunotherapy, Inc. Recombinant vaccinia virus and methods of use thereof
US11685904B2 (en) 2019-02-14 2023-06-27 Ignite Immunotherapy, Inc. Recombinant vaccinia virus and methods of use thereof
BR112021019701A2 (pt) 2019-04-02 2021-12-14 Kenjockety Biotechnology Inc Anticorpos multiespecíficos para antígeno de câncer de bomba de efluxo e composições, reagentes, kits e métodos relacionados aos mesmos
CA3163805A1 (en) 2019-12-12 2021-06-17 Ignite Immunotherapy, Inc. Variant oncolytic vaccinia virus and methods of use thereof
CA3164608A1 (en) 2020-01-29 2021-08-05 Kenjockety Biotechnology, Inc. Anti-mdr1 antibodies and uses thereof
US20230212305A1 (en) 2020-06-04 2023-07-06 Kenjockety Biotechnology, Inc. Anti-abcg2 antibodies and uses thereof
WO2021247423A1 (en) 2020-06-04 2021-12-09 Kenjockety Biotechnology, Inc. Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
CA3189291A1 (en) 2020-07-14 2022-01-20 Pfizer Inc. Recombinant vaccinia virus
CN116490522A (zh) 2020-09-02 2023-07-25 肯乔克蒂生物技术股份有限公司 抗abcc1抗体及其应用
US20240010747A1 (en) 2020-11-13 2024-01-11 Kenjockety Biotechnology, Inc. Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
JP2023551203A (ja) 2020-11-20 2023-12-07 アール.ピー.シェーラー テクノロジーズ、エルエルシー 抗体-薬物コンジュゲートのためのグリコシド二重切断リンカー
CN112694458A (zh) * 2020-12-29 2021-04-23 重庆臻源红豆杉发展有限公司 一种10-去乙酰基巴卡亭ⅲ提取纯化方法
AU2022413942A1 (en) 2021-12-13 2024-05-30 William Robert Arathoon Living Trust Dated August 29, 2016 Anti-abcb1 antibodies
WO2023159220A1 (en) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anti-cd47 antibodies

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601676B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5019504A (en) * 1989-03-23 1991-05-28 The United States Of America As Represented By The Secretary Of Agriculture Production of taxol or taxol-like compounds in cell culture
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5380916A (en) 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5279953A (en) * 1992-06-24 1994-01-18 Esca Genetics Corporation In vivo production of taxanes
FR2696463B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
FR2703049B1 (fr) * 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Procédé de purification des taxoïdes.

Also Published As

Publication number Publication date
ATE147381T1 (de) 1997-01-15
NZ256449A (en) 1996-09-25
FR2696462B1 (fr) 1994-11-25
CA2146248A1 (fr) 1994-04-14
PL173993B1 (pl) 1998-05-29
CN1041310C (zh) 1998-12-23
CA2470124A1 (fr) 1994-04-14
US5736366A (en) 1998-04-07
AU5115493A (en) 1994-04-26
ES2095672T3 (es) 1997-02-16
EE03124B1 (et) 1998-10-15
JP3299753B2 (ja) 2002-07-08
GR3022229T3 (en) 1997-04-30
CA2146248C (fr) 2006-12-12
TW404944B (en) 2000-09-11
JPH08501791A (ja) 1996-02-27
SK43195A3 (en) 1995-08-09
FI951590L (fi) 1995-04-04
NO310414B1 (no) 2001-07-02
LV10620B (en) 1995-10-20
DK0663909T3 (no) 1997-01-27
DE69307333D1 (de) 1997-02-20
HUT72678A (en) 1996-05-28
FR2696462A1 (fr) 1994-04-08
SK280335B6 (sk) 1999-12-10
RU95110662A (ru) 1996-12-27
UA40601C2 (uk) 2001-08-15
MX9305770A (es) 1994-05-31
FI109797B (fi) 2002-10-15
HU225969B1 (en) 2008-01-28
PL308243A1 (en) 1995-07-24
GEP19981433B (en) 1998-10-30
KR100301238B1 (ko) 2001-11-22
AU680440B2 (en) 1997-07-31
EP0663909A1 (fr) 1995-07-26
EP0663909B1 (fr) 1997-01-08
CA2470124C (fr) 2007-08-07
KR950703549A (ko) 1995-09-20
CZ84495A3 (en) 1995-09-13
RU2108330C1 (ru) 1998-04-10
CN1085552A (zh) 1994-04-20
ZA937312B (en) 1994-04-25
LT3465B (en) 1995-10-25
CZ286452B6 (en) 2000-04-12
LV10620A (lv) 1995-04-20
DE69307333T2 (de) 1997-04-30
HU9500969D0 (en) 1995-06-28
US5393896A (en) 1995-02-28
WO1994007881A1 (fr) 1994-04-14
LTIP1398A (en) 1994-11-25
CZ286593B6 (cs) 2000-05-17
FI951590A0 (fi) 1995-04-04
NO951281L (no) 1995-04-03

Similar Documents

Publication Publication Date Title
NO951281L (no) Fremgangsmåte for fremstilling av 10-desacetyl-baccatin-III
EE03126B1 (et) Meetod 10-desatsetüülbakatiin III saamiseks ja 10-desatsetüülbakatiin III kasutamine
DK0863887T3 (da) Mellemprodukter til hemisyntese af taxaner og fremgangsmåder til deres fremstilling
FR2703049B1 (fr) Procédé de purification des taxoïdes.
ATE273945T1 (de) Verfahren zur kristallisierung von sterisch gehinderten verbindungen
NO20052329L (no) Fremgangsmate for rensingen av 1,4-butandiol-mononitrat
DK0508233T3 (da) Fremgangsmåde til fremstilling af ascorbinsyre-2-monophosphater ved tørring

Legal Events

Date Code Title Description
MK1K Patent expired